Read Here Why Did This Analyst Cut DexCom's Price Target
DXCMApril 29, 2022
Read more →Raymond James Maintains Outperform on DexCom, Lowers Price Target to $486
DXCMApril 29, 2022
Read more →Morgan Stanley Maintains Equal-Weight on DexCom, Lowers Price Target to $492
DXCMApril 29, 2022
Read more →Piper Sandler Maintains Overweight on DexCom, Lowers Price Target to $480
DXCMApril 29, 2022
Read more →SVB Leerink Maintains Outperform on DexCom, Lowers Price Target to $500
DXCMApril 29, 2022
Read more →Recap: DexCom Q1 Earnings
DXCMDexCom (NASDAQ:DXCM) reported its Q1 earnings results on Thursday, April 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings DexCom missed estimated earnings by 38.46%, reporting an EPS of $0.32 versus an estimate of $0.52.
April 28, 2022
Read more →DexCom Q1 EPS $0.32 Misses $0.52 Estimate, Sales $628.80M Beat $623.36M Estimate
DXCMApril 28, 2022
Read more →